1. Antimotion-sickness efficacy of scopolamine 12 and 72 h after transdermal administration;Graybiel;Aviat. Space Environ. Med.,1982
2. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine;Graybiel;Aviat. Space Environ. Med.,1981
3. Transdermal scopolamine, oral meclizine, and placebo in motion sickness;Dahl;Clin. Pharmacol. Ther.,1984
4. The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting;Antor;Front. Pharmacol.,2014
5. Control of drooling using transdermal scopolamine skin patches. A case report;Mato Montero;Med. Oral Patol. Oral Cir. Bucal,2008